Usefulness of inspiratory capacity measurement in COPD patients in the primary care setting

International Journal of General Medicine

Volumn 2, Issue , 2009, Pages 219-225

  Madueño, Antonio ^a   Martín, Antonio ^b   Péculo, Juan Antonio ^c   Antón, Esther ^b   Paravisini, Alejandra ^b   León, Antonio ^d  

^a Centro de Salud la Laguna   (Spain)

^b PFIZER INC   (United States)

^c Servicio 061   (Spain)

^d HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

COPD; Inspiratory capacity; Primary care; Quality of life

Indexed keywords

ADULT; AGED; ANTHROPOMETRY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; EXPIRATORY RESERVE VOLUME; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INSPIRATORY CAPACITY; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIMARY MEDICAL CARE; QUALITY OF LIFE; SPAIN; VITAL CAPACITY;

EID: 77953382019     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Celli B, MacNee W. ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD. Eur Respir J. 2004;23:932-946.
2. Barberá JA, Peces Barba G, Agusti AG, et al. Sociedad Española de Neumologia y Cirugia Toracica (SEPAR). Guía clínica para el diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica. Arch Bronconeumol. 2001;37:297-316.
3. Kilian K, Jones N. Respiratory muscles and dyspnea. Clin Chest Med. 1988;9:237-248.
4. Fabbri LM, Hurd SS. GOLD Scientific Committee. Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update. Eur Respir J. 2003;22:1-2.
5. Izquierdo Alonso JL. Valoración funcional de la EPOC. Arch Bronconeumol. 2001;37(Suppl 2):2-8.
6. O'Donnell DE, Fluge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnea and exercise tolerance in COPD. Eur Respir J. 2004;117(Suppl 12A):49S-59S.
7. Grupo de trabajo de la SEPAR para la práctica de la espirometría en clínica. Recomendaciones SEPAR. Normativa para la práctica de la espirometría forzada. Arch Bronconeumol. 1989;25:132-141.
8. Anthonisen NR, Manfreda J, Warren CPW, Hershfield ES, Harding GKM, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106:196-204.
9. Fernandez Vargas AM, Bujalance Zafra MJ, Leiva Fernandez F, Martos Crespo F, García Ruíz A, Prados Torres D. Correlación entre medidas de salud subjetivas y objetivas en pacientes con enfermedad pulmonar obstructiva crónica (EPOC). Atención Primaria. 2001;28:579-589.
10. Roca J, Sanchis J, Augusti-Vidal A, et al. Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir. 1986;22:217-224.
11. Air pollution and chronic or repeated respiratory diseases. II. Results and discussion. Bull Eur Physiopathol Respir. 1982;18:101-102.
12. Ferrer M, Alonso J, Prieto L, et al. Validity and reliability of the St. George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example. Eur Respir J. 1996;9: 1160-1166.
13. Ferrer M, Alonso J, Morera J, et al; Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann Intern Med. 1997;127:1072-1079.
14. Badia X, Salamero M, Alonso J. La Medida de la Salud. Guía de escalas de medición en español. Cuestionario Respiratorio St. George. Edimac edit. Barcelona, Spain: Press Line; 1999. p. 175-181.
15. Tinkelman DG, Price DB, Nordyke RJ, et al. Symptom-based questionnaire for fifferentiating COPD and asthma. Respiration. 2006;73: 296-305.
16. Peña VS, Miravitlles M, Gabriel R, et al; Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest. 2000;118(4):981-989.
17. Rabe KF, Beghé B, Luppi F, Fabbri LM. Update in chronic obstructive pulmonary disease 2006. Am J Respir Crit Care Med. 2007;175: 1222-1232.
18. Eaton T, Withy S, Garrett JE, Mercer J, Whitlock RM, Rea HH. Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. Chest. 1999;116(2):416-423.
19. O'Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:770-777.
20. Rothpearl A, Varma AO, Goodman K. Radiographic measures of hyperinflation in clinical emphysema. Discrimination of patients from controls and relationship to physiologic and mechanical lung function. Chest. 1988;94:907-913.
21. Marín Trigo JM. Manifestaciones clínica: la disnea y su importancia en el paciente con EPOC. Arch Bronconeumol. 2001;37(Suppl 2):8-13.
22. Cooper CB. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med. 2006;119(10A):S21-S31.
23. Marín JM, Carrizo SJ, Gascón M, Sánchez A, Gallego B, Celli BR. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163:1395-1399.
24. Belman MG, Botnick WC, Shin JW. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;153:967-975.
25. Celli B, ZuWallack R, Wang S, Kesten S. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest. 2003;124: 1743-1748.
26. Pitta F, Takaki MY, de Oliveira NH, et al. Relationship between pulmonary function and physical activity in daily life in patients with COPD. Respir Med. 2008;102:1203-1207.